Skip to main content
. 2020 Aug 28;46(5):1805–1815. doi: 10.3892/ijmm.2020.4715

Figure 1.

Figure 1

Expression of HOXA11-AS and miR-506-3p in HCC tissues and cell lines. (A and B) The expression of (A) HOXA11-AS and (B) miR-506-3p was measured by RT-qPCR in 39 pairs of HCC tissues and adjacent non-tumor tissues. (C) Correlation between HOXA11-AS and miR-506-3p (r=−0.610, P<0.001). (D and E) Expression of (D) HOXA11-AS and (E) miR-506-3p in HCC cell lines (Huh7, Hep3B, PLC/PRF/5 and MHCC97-H) and THLE-3 cells. (F) RT-qPCR was used to assess the level of the cytoplasmic control transcript (GAPDH), nuclear control transcript (U6) and HOXA11-AS in the nuclear and cytoplasmic fractions. *P<0.05 vs. respective control. HCC, hepatocellular carcinoma.